My involvement in patient care as a pharmacist entails: | Not at all n (%) | Rarely n (%) | Occasionally n (%) | Frequently n (%) |
---|---|---|---|---|
1.Explain misconceptions about addictive medication (n = 110) | 7 (6.4) | 18 (16.4) | 37 (33.6) | 48 (43.6) |
2. Visit patients’ homes to communicate directly with patients and their caregivers and to make necessary assessments (n = 110) | 60 (54.5) | 36 (32.7) | 11 (10.0) | 3 (2.7) |
3. Monitor patients’ medication profile for safety and effectiveness (n = 109) | 2 (1.8) | 31 (28.4) | 33 (30.3) | 43 (39.4) |
4. Provide patients with essential medications that ensure continuous symptom control (n = 110) | 14 (12.7) | 6 (5.5) | 15 (13.6) | 75 (68.2) |
5. Attend clinical meetings to advise other members of healthcare team about medication therapy (n = 110) | 12 (10.9) | 22 (20.0) | 45 (40.9) | 31 (28.2) |
6. Advise clinical team on dosage forms and adjustments, routes of administration, costs, and availability of various drug products (n = 110) | 15 (13.6) | 13 (11.8) | 42 (38.2) | 40 (36.4) |
7. Give educational sessions (n = 110) | 15 (13.6) | 23 (20.9) | 47 (42.7) | 25 (22.7) |
8. Advise members of the clinical team about the potential for toxicity and interactions with dietary supplements and alternative therapies (n = 110) | 13 (11.8) | 34 (30.9) | 37 (33.6) | 26 (23.6) |
9. Ensure that all medication labeling is complete and understandable by patients and their caregivers (n = 110) | 4 (3.6) | 4 (3.6) | 2 (1.8) | 100 (90.9) |
10. Communicate with patients about the importance of adhering to the prescribed drug regimen (n = 110) | 0 (0.0) | 4 (3.6) | 6 (5.5) | 100 (90.9) |
11. Monitor all prescription and nonprescription medication use (n = 108) | 3 (2.8) | 7 (6.5) | 38 (35.2) | 60 (55.5) |
12. Counsel patients about potential toxicity of alternative and complementary therapies (n = 109) | 2 (1.8) | 9 (8.3) | 35 (32.1) | 63 (57.8) |
13. Extemporaneous preparation of non-conventional dosage forms for ease of administration to patients (n = 109) | 4 (3.7) | 5 (4.6) | 28 (25.7) | 72 (66.1) |
14. Prepare flavouring medications to promote compliance (n = 103) | 5 (4.9) | 16 (15.5) | 40 (38.8) | 42 (40.8) |
15. Address issues on cost of patients’ medications (n = 110) | 6 (5.5) | 12 (10.9) | 43 (39.1) | 49 (44.5) |
16. Ensure that drug disposal is in compliance with federal and state drug control and environmental protection laws and regulations (n = 103) | 3 (2.9) | 16 (15.5) | 26 (25.2) | 58 (56.3) |